Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

ADHD Therapeutics Companies

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity. The treatment of ADHD often involves a combination of behavioral interventions, psychoeducation, and pharmacotherapy. Several pharmaceutical companies are involved in the development and production of medications used in the management of ADHD symptoms.

Latest ADHD Therapeutics Companies Updates:

This US-based company is preparing to submit a New Drug Application (NDA) for its once-daily ADHD medication, CTx-1301, by mid-2024.CTx-1301 uses Cingulate's innovative Precision Timed Release (PTR) technology to deliver three timed doses of dexmethylphenidate throughout the day, potentially improving patient adherence and reducing side effects.Positive top-line results from Phase III trials in adults have already been announced, with pediatric and adolescent trials slated for August 2023.

ABVC, a clinical-stage biopharmaceutical company, secured a US patent for the use of PDC-1421, a Radix Polygala extract, in its ADHD drug ABV-1505.ABV-1505 acts as a Norepinephrine Transporter (NET) inhibitor, a novel approach to treating ADHD with fewer side effects than traditional stimulants.Phase IIa trials have shown promise, with Phase IIb results expected by year-end, potentially positioning ABVC for a unique entry into the market.

List of ADHD Therapeutics Key companies in the market:

Advanz Pharmaceutical (Canada)

Eli Lilly and Company (US)

Highland Therapeutics Inc. (Canada)

Janssen Pharmaceuticals, Inc. (Belgium)

NEOS Therapeutics, Inc. (US)

Pfizer Inc. (US)

Novartis AG (Switzerland)

Noven Pharmaceuticals, Inc. (US)

ADHD Therapeutics Market Highlights:

ADHD Therapeutics Market Size

ADHD Therapeutics Market Trends

ADHD Therapeutics Market Analysis

ADHD Therapeutics Market Share

ADHD Therapeutics Market Highlights:

ADHD Therapeutics Market Trends

ADHD Therapeutics Market Analysis

ADHD Therapeutics Market Share

ADHD Therapeutics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.